3646 results for «484»
3646 results
The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes
21 Nov 2021 – From PCR London Valves 2021
In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.
...Not just TAVI
21 Nov 2021 – From PCR London Valves 2021
Browse this page to discover simultaneous TAVR and tricuspid valve-in-valve, combined percutaneous valve-in-valve TAVI and mitral repair in degenerated freestyle full root, paravalvular leak post TAVR causing hemolysis treated with balloon dilatation and PVL closure, and much more!
Best cases session
21 Nov 2021 – From PCR London Valves 2021
This session from the PCR London Valves 2021 Congress compiles a series of the best cases submitted during this edition. Discover, among others, cases of severe aortic valve and ostial coronary disease, as well as transcatheter valvular lithotripsy in cases with severely calcific aortic or mitral...
Best cases and research unveiled at AICT-Asia PCR 2021
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
